|
GANX Gain Therapeutics Inc 1819411 |
| Balance Sheet |
|
Current Assets
|
$14,969,748.00 |
|
Assets
|
$15,421,939.00 |
|
Current Liabilities
|
$3,433,865.00 |
|
Liabilities
|
$4,129,908.00 |
|
Equity
|
$11,292,031.00 |
|
Shares Out
|
43340501.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,407,532.00 |
|
Investing Cash Flow
|
$4,977,507.00 |
| Market Analysis |
Market Cap
|
$85,814,191.98 |
|
Price
|
$1.98 |
|
BVPS
|
0.26 |
|
PB
|
7.62 |
|
EPS
|
-0.11 |
|
PS
|
1555.17 |
|
FCF
|
$-9,430,025.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:52 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GANX documents filed with the SEC.
GANX Filings
Clear
